Previous Page
16
nanotimes
Companies Facts
Companies – Summaries 3
M Twin Axial Ribbon Cable, SL8800 Series solution was announced as a recipient of R&D
Magazine’s 49th Annual R&D 100 Awards. The award recognizes 100 of the most technologically significant products and has long been a benchmark of excellence in a variety of industries – from aca- demia to government to medical to manufacturing. 3M’s newest innovation joins a distinguished group of past R&D 100 Award recipients, including the fax machine, liquid crystal display, HDTV, and company solutions 3M Aluminum Conductor Composite Rein- forced (ACCR) and 3M Cubitron™ II abrasives.
3M has completed its acquisition of Advanced Che- mistry & Technology Inc. (AC TECH), a manufac- turer of quick cure, light-weight polysulfide sealants for aerospace applications based in Garden Grove, Calif. Terms of the transaction were not disclosed. The addition of AC TECH’s range of fast-curing polysulfide sealants expands 3M’s product presence in the aerospace market for the manufacture and maintenance of commercial and military aircraft. AC TECH and 3M working together will better serve customers in the aerospace industry.
modeling and simulation software. The release in- corporates the first commercially available software
A
ccelrys, Inc. (NASDAQ:ACCL) announced a new release of the Discovery Studio®
life sciences
for predicting protein-protein aggregation to advance biotherapeutics research. In addition, a major update to the software’s 3D-molecular ActiveX control ena- bles researchers to display dynamic molecular visua- lizations in webpages, Microsoft Office® and Microsoft SharePoint®
applications collaboration software.
Furthermore, Accelrys announced that a continuing partnership with Toronto-based chemistry software company ACD/Labs is enabling pharmaceutical, chemical and biochemical companies around the world to work more efficiently and productively by deploying ACD/Labs analytical component collection on the Accelrys Pipeline Pilot™ enterprise R&D platform.
http://www.acdlabs.com http://www.accelrys.com
medicine, announced that the European Medicines Agency‘s (EMA) Committee for Orphan Medicinal Products (COMP) has officially granted ACT‘s human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells designation as an orphan medi- cinal product for the treatment of Stargardt‘s Macular Dystrophy (SMD). This follows on the U.S. Food & Drug Administration‘s (FDA) granting of Orphan Drug De-
A
dvanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative
11-06/07 :: June/July 2011